Tracked vehiclesAnduril Enterprise 0.87% fill $173.4M / $20BCBP AST 46.50% fill $929.9M / $2.0BPalantir Maven 81.60% fill $637.6M / $781.3MShield AI USCG $61.4M drawn 12 ordersCounter-drone $2.1B drawn 25 C-UAS vehicles and awardsUSAspending compile · Oct 9 2026
AwardTape

AwardTape · Defense awards · Research and development · Science and technology R&D · W912HZ21C0009

W912HZ21C0009: -$9.3K definitive contract to Creare LLC

Creare LLC holds a definitive contract from Department of the Army with -$9.3K obligated since Oct 2023 and $241K obligated over its life, against a ceiling of $241K. Latest action Oct 7, 2024.

Sbir phase iii geowatch

PIIDW912HZ21C0009
Typedefinitive contract
CompanyCreare LLC
AgencyDepartment of the Army
Contracting officeW2R2 USA ENGR R & D CTR
CategoryResearch and development · Science and technology R&D
PSCAJ12 GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
NAICS541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Obligated since Oct 2023-$9.3K
Total obligated (lifetime)$241K
Ceiling (base and all options)$241K
Base dateJan 29, 2021
Latest actionOct 7, 2024
End dateJan 28, 2022
Actions since Oct 20231
PricingCost plus fixed fee
CompetitionNot competed
Place of performanceNH
SourceUSAspending.gov record
Reporting lagDoD 90 days
About this record

Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.

Terminal: alerts on new orders and modifications to this contract, and CSV export.

7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.

Start free trial